RMFEX
Price
$56.11
Change
+$0.29 (+0.52%)
Updated
Jan 17 closing price
Net Assets
103.41B
VWNAX
Price
$80.85
Change
+$0.53 (+0.66%)
Updated
Jan 17 closing price
Net Assets
59.78B
Ad is loading...

RMFEX vs VWNAX

Header iconRMFEX vs VWNAX Comparison
Open Charts RMFEX vs VWNAXBanner chart's image
American Funds American Mutual R4
Price$56.11
Change+$0.29 (+0.52%)
VolumeN/A
Net Assets103.41B
Vanguard Windsor™ II Admiral™
Price$80.85
Change+$0.53 (+0.66%)
VolumeN/A
Net Assets59.78B
RMFEX vs VWNAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMFEX vs. VWNAX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFEX is a Buy and VWNAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 103B vs. VWNAX (59.8B). RMFEX pays higher dividends than VWNAX: RMFEX (1.95) vs VWNAX (1.53). RMFEX was incepted earlier than VWNAX: RMFEX (23 years) vs VWNAX (24 years). RMFEX is a more actively managed with annual turnover of: 25.00 vs. VWNAX (17.00). RMFEX has a lower initial minimum investment than VWNAX: RMFEX (250) vs VWNAX (50000). RMFEX annual gain was more profitable for investors over the last year : 12.78 vs. VWNAX (7.41). RMFEX return over 5 years is better than : 39.96 vs. VWNAX (21.87).
RMFEXVWNAXRMFEX / VWNAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years24 years-
Gain YTD2.1672.92874%
Front LoadN/AN/A-
Min. Initial Investment250500001%
Min. Initial Investment IRAN/AN/A-
Net Assets103B59.8B172%
Annual Yield % from dividends1.951.53127%
Returns for 1 year12.787.41172%
Returns for 3 years13.63-0.01-110,191%
Returns for 5 years39.9621.87183%
Returns for 10 years71.4125.25283%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMMT19.030.84
+4.62%
Summit Therapeutics
ZLAB26.050.67
+2.64%
Zai Lab Limited
ASIX31.580.72
+2.33%
AdvanSix
PLX2.220.05
+2.30%
Protalix BioTherapeutics
VRAX2.180.04
+1.87%
Virax Biolabs Group Limited